A carregar...
The Value of OCT and OCTA as Potential Biomarkers for Preclinical Alzheimer’s Disease: A Review Study
Preclinical Alzheimer’s disease (AD) includes cognitively healthy subjects with at least one positive biomarker: reduction in cerebrospinal fluid Aβ(42) or visualization of cerebral amyloidosis by positron emission tomography imaging. The use of these biomarkers is expensive, invasive, and not alway...
Na minha lista:
| Publicado no: | Life (Basel) |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8306512/ https://ncbi.nlm.nih.gov/pubmed/34357083 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/life11070712 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|